EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Pre-Launch

emtricitabine; tenofovir disoproxil fumarate

Matrix Surgical USA
ANDAORALTABLET
Lifecycle
Pre-Launch

Mechanism of Action

fixed-dose combination of antiviral drugs FTC and TDF [see ] .

Indications (4)

at-risk adultsadolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infectioncombination with other antiretroviral agents for the treatment of HIV-1 infection in adultscombination with other antiretroviral agents
Company
Matrix Surgical USA
Matrix Surgical USA
GA - Newnan
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history